In this presentation we provide the evidence that dengue fever is transmissible through blood transfusions. A discussion can be found at The Brazilian Blood Journal.
MERS has to be tackled more practically ,its nothing to scare unless you find and suspicious case around you.The contributing factors are ,weather ,closed homes ,shisha culture ,and the anatomy of Arabs nostrils play a aggressive role in spread of this new disease.The virus mutated recently in a more more cases in humans appeared in hospitals in Jeddah, which may indicate increased virus transmission from man to man due to mutation in the genome leading to virus adaptation. This event may be associated with loss of some virulence elements in the virus.”to survive, viruses adapt or evolve, changing its surface proteins enough to trick the host cell into allowing it to attach.
Land use, biodiversity changes and the risk of zoonotic diseases: Findings fr...ILRI
Presented by B. Bett, M. Said, R. Sang, S. Bukachi, J. Lindahl, S. Wanyoike, E. Ontiri, I. Njeru, J. Karanja, F. Wanyoike, D. Mbotha and D. Grace at the 49th Kenya Veterinary Association annual scientific conference, Busia, Kenya, 22-25 April 2015.
MERS has to be tackled more practically ,its nothing to scare unless you find and suspicious case around you.The contributing factors are ,weather ,closed homes ,shisha culture ,and the anatomy of Arabs nostrils play a aggressive role in spread of this new disease.The virus mutated recently in a more more cases in humans appeared in hospitals in Jeddah, which may indicate increased virus transmission from man to man due to mutation in the genome leading to virus adaptation. This event may be associated with loss of some virulence elements in the virus.”to survive, viruses adapt or evolve, changing its surface proteins enough to trick the host cell into allowing it to attach.
Land use, biodiversity changes and the risk of zoonotic diseases: Findings fr...ILRI
Presented by B. Bett, M. Said, R. Sang, S. Bukachi, J. Lindahl, S. Wanyoike, E. Ontiri, I. Njeru, J. Karanja, F. Wanyoike, D. Mbotha and D. Grace at the 49th Kenya Veterinary Association annual scientific conference, Busia, Kenya, 22-25 April 2015.
Pre-empting the emergence of zoonoses by understanding their socio-ecologyNaomi Marks
Keynote presentation by Dr Peter Daqszak, President, EcoHealth Alliance, at the One Health for the Real World: zoonoses, ecosystems and wellbeing symposium, London 17-18 March 2016
This paper reviews the evolution of the definition of sepsis and the controversy surrounding the sepsis-3 definition and the sepsis screening tool, qSOFA.
Austin Journal of Vector Borne Diseases: Open Access is an open access, peer reviewed, scholarly journal dedicated to publish articles in all areas of vector borne diseases including existing or new policy in the relevant areas, impact of all types of vector borne diseases and related medical research methodologies.
Vector-borne diseases are the infections transmitted by the bite of infected arthropod species, such as mosquitoes, ticks, triatomine bugs, sandflies, and blackflies. Arthropod vectors are cold-blooded (ectothermic) and thus especially sensitive to climatic factors. Or Vectors are organisms that transmit pathogens and parasites from one infected person (or animal) to another, causing serious diseases in human populations. These diseases are commonly found in tropical and sub-tropical regions and places where access to safe drinking-water and sanitation systems is problematic.
Austin Journal of vector borne diseases welcomes research manuscripts, review articles, case reports, editorials, letters to the editor, and innovations relating to all aspects of vector borne diseases.
This is an abbreviated version of the CDC's Sept 16 COCA conference call. I also uploaded a longer abbreviation. See this document for the web address of the original verison.
Irrigation and the risk of Rift Valley fever transmission - a case study from...Naomi Marks
Presentation by Dr Bernard Bett of the International Livestock Research Institute, Nairobi, at the One Health for the Real World: zoonoses, ecosystems and wellbeing symposium, London 17-18 March 2016
Disease frequency of selected bacterial zoonoses in small ruminants in Tana R...ILRI
Poster prepared by Martin Wainaina, Johanna Lindahl, Anne Mayer-Scholl, Kristina Roesel, Deborah Mbotha, Uwe Roesler, Delia Grace, Bernard Bett and Sascha Al Dahouk for the Kenya One Health Online Conference, 6-8 December 2021
Pre-empting the emergence of zoonoses by understanding their socio-ecologyNaomi Marks
Keynote presentation by Dr Peter Daqszak, President, EcoHealth Alliance, at the One Health for the Real World: zoonoses, ecosystems and wellbeing symposium, London 17-18 March 2016
This paper reviews the evolution of the definition of sepsis and the controversy surrounding the sepsis-3 definition and the sepsis screening tool, qSOFA.
Austin Journal of Vector Borne Diseases: Open Access is an open access, peer reviewed, scholarly journal dedicated to publish articles in all areas of vector borne diseases including existing or new policy in the relevant areas, impact of all types of vector borne diseases and related medical research methodologies.
Vector-borne diseases are the infections transmitted by the bite of infected arthropod species, such as mosquitoes, ticks, triatomine bugs, sandflies, and blackflies. Arthropod vectors are cold-blooded (ectothermic) and thus especially sensitive to climatic factors. Or Vectors are organisms that transmit pathogens and parasites from one infected person (or animal) to another, causing serious diseases in human populations. These diseases are commonly found in tropical and sub-tropical regions and places where access to safe drinking-water and sanitation systems is problematic.
Austin Journal of vector borne diseases welcomes research manuscripts, review articles, case reports, editorials, letters to the editor, and innovations relating to all aspects of vector borne diseases.
This is an abbreviated version of the CDC's Sept 16 COCA conference call. I also uploaded a longer abbreviation. See this document for the web address of the original verison.
Irrigation and the risk of Rift Valley fever transmission - a case study from...Naomi Marks
Presentation by Dr Bernard Bett of the International Livestock Research Institute, Nairobi, at the One Health for the Real World: zoonoses, ecosystems and wellbeing symposium, London 17-18 March 2016
Disease frequency of selected bacterial zoonoses in small ruminants in Tana R...ILRI
Poster prepared by Martin Wainaina, Johanna Lindahl, Anne Mayer-Scholl, Kristina Roesel, Deborah Mbotha, Uwe Roesler, Delia Grace, Bernard Bett and Sascha Al Dahouk for the Kenya One Health Online Conference, 6-8 December 2021
Presentation made to CoastNerds November 2010 by Scott Wallace and Robert Dyball. Entitled "Test Driven Development - A Testing Journey", it describes the path we've started in agile development through test last, test first, TDD, ATDD and on to BDD. (The principles in the presentation apply to any language.)
In this session, you'll learn about:
• Defining a inbound marketing strategy to identify your current priorities
• Executing a plan to drive the lead and sales you need to reach your growth goals
• Evolving your strategy to develop healthy and scalable strategic planning habits
Originally presented as a webinar by Whole Brain Group CEO, Marisa Smith and HubSpot Director, Dan Tyre on October 30, 2013.
Soho Residences » Apartamentos de 1, 2, 3 e 4 quartos, composto por 2 torres residenciais, 42 lojas, 16 salas comerciais e lazer para toda família em Botafogo, no Rio de Janeiro, RJ » Ficha Técnica e Fotos do Imóvel na Planta. Imobiliaria Patrimóvel. Reservas e Vendas: +55 (21) 3253-2797
U.S. Preps For Ebola Outbreak Cases May Exceed 100,000 By December “The Numbe...Hope Small
The article does not mention that a completely unrelated strain of ebola has broken out in the Congo. What are the chances of that?
Though news on the Ebola virus has been muted since two American health care workers were admitted to U.S.-based facilities last month, the deadly contagion continues to spread. According to the World Health Organization more than 40% of all Ebola cases thus far have occurred in just the last three months, suggesting that the virus is continuing to build steam.
Physicist Alessandro Vespignani of Northeastern University in Boston is one of several researchers trying to figure out how far Ebola may spread and how many people around the world could be affected. Based on his findings, there will be 10,000 cases by September of this year and it only gets worse from there.
Bio303 Lecture Three: New Foes, Emerging InfectionsMark Pallen
New foes. In this lecture I will describe emerging infections, their epidemiology and ecology and the threats that they pose. I will focus on three case studies: SARS, pandemic flu (with help from Jennifer Gardy) and the German STEC outbreak of May-June 2011
1-What are the challenges in combating emerging and reemerging disease.docxKevinjrHWatsono
1.What are the challenges in combating emerging and reemerging diseases?
2.Discuss some of the examples given your book.
3.Some steps we can take to prevent an outbreak of the diseases.
Emerging Infectious Diseases LEARNING OBJECTIVE 14-19 List several probable reasons for emerging infectious diseases, and name one example for each reason. Emerging infectious diseases (EIDs) are diseases that are new or changing, are showing an increase in incidence in the CHAPER 14 . Princlples of Disease and Epidemiologg 411. recem past, or show a potential to increase in the near future (see Chapter 1). An emerging disease can be caused by a virus. a bacterium, a fungus, a protonoan, or a helminth. About 75% of emerging infectious diseases are zoonotic, mainly of viral origin, and are likely to be vecton borne. Several criteria are used for identifyiog an HiD, For exam. ple, some diseases present symptoms that are cleady disinctive from all other diseases. Some are recogrized because improved diagnostic techniques allow the identification of a new parbogen. Others are identified when a local disease becoines widespread, a rare diskase becomes common, a mild diseas becomes more severe, or an increase in life span permits a alow. disease to develop. Examples of emerging infectious diseases are listed in Table 14.5 and described in the boses in Chapters 8 and 13 (pages 218 . and 367 ) . A variety of factoss contribute to the emerpence of nicw infectious diseases: - New srains, such as E. coli 0157417 and avian influcaza (H5N1). may result from genetic recoenbination between organisms. - A new serovar, sich as Videio dolerae O139, may resulh from changes in or the evolution of existing microorga niams. - The widespread, and sometimes unwarranted, use of antiblotics and pesticides encourages the growth of mote resistant populations of microbes and the vectors (mosquitoes, lice, and eicks) that carry then. - Clobal warming and changes in weather patterns mayy increase the distribution and survival of reervairs and vectors. resulting in the insrodaction and dissemination of diseases. such as malaria and Handavines palmonary syndrome. - Known diseases, such as Zika virus discase, chikungganya. dengue, and West Nile encephalitis, may spread to new geographic areas by modern transportation. This was less likely 100 years ago, when tavel took vo long that infected traveless either died or recovered during passage - Insect vectors transported to new areas can transmit infections brought by human traveles. The African yellow fever mosquito. Aedes aedppli came to the Anecicas with the first European explorers. Yellow ficver yinus was also. brought to the Americas with those first exploren, and A aegypti transmitted the disease to native populations and immigrants alike. The A sian eiger mosquito, A . allopitrie, was. inadvertently brought to Texas on a cargo ship from lapan in 1985. Both Ades ypecies are now estaklished throughout the southem and southwestern stares..
Similar to Dengue Fever and Blood Transfusion (20)
Explore natural remedies for syphilis treatment in Singapore. Discover alternative therapies, herbal remedies, and lifestyle changes that may complement conventional treatments. Learn about holistic approaches to managing syphilis symptoms and supporting overall health.
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?bkling
Are you curious about what’s new in cervical cancer research or unsure what the findings mean? Join Dr. Emily Ko, a gynecologic oncologist at Penn Medicine, to learn about the latest updates from the Society of Gynecologic Oncology (SGO) 2024 Annual Meeting on Women’s Cancer. Dr. Ko will discuss what the research presented at the conference means for you and answer your questions about the new developments.
Prix Galien International 2024 Forum ProgramLevi Shapiro
June 20, 2024, Prix Galien International and Jerusalem Ethics Forum in ROME. Detailed agenda including panels:
- ADVANCES IN CARDIOLOGY: A NEW PARADIGM IS COMING
- WOMEN’S HEALTH: FERTILITY PRESERVATION
- WHAT’S NEW IN THE TREATMENT OF INFECTIOUS,
ONCOLOGICAL AND INFLAMMATORY SKIN DISEASES?
- ARTIFICIAL INTELLIGENCE AND ETHICS
- GENE THERAPY
- BEYOND BORDERS: GLOBAL INITIATIVES FOR DEMOCRATIZING LIFE SCIENCE TECHNOLOGIES AND PROMOTING ACCESS TO HEALTHCARE
- ETHICAL CHALLENGES IN LIFE SCIENCES
- Prix Galien International Awards Ceremony
Couples presenting to the infertility clinic- Do they really have infertility...Sujoy Dasgupta
Dr Sujoy Dasgupta presented the study on "Couples presenting to the infertility clinic- Do they really have infertility? – The unexplored stories of non-consummation" in the 13th Congress of the Asia Pacific Initiative on Reproduction (ASPIRE 2024) at Manila on 24 May, 2024.
Title: Sense of Smell
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the primary categories of smells and the concept of odor blindness.
Explain the structure and location of the olfactory membrane and mucosa, including the types and roles of cells involved in olfaction.
Describe the pathway and mechanisms of olfactory signal transmission from the olfactory receptors to the brain.
Illustrate the biochemical cascade triggered by odorant binding to olfactory receptors, including the role of G-proteins and second messengers in generating an action potential.
Identify different types of olfactory disorders such as anosmia, hyposmia, hyperosmia, and dysosmia, including their potential causes.
Key Topics:
Olfactory Genes:
3% of the human genome accounts for olfactory genes.
400 genes for odorant receptors.
Olfactory Membrane:
Located in the superior part of the nasal cavity.
Medially: Folds downward along the superior septum.
Laterally: Folds over the superior turbinate and upper surface of the middle turbinate.
Total surface area: 5-10 square centimeters.
Olfactory Mucosa:
Olfactory Cells: Bipolar nerve cells derived from the CNS (100 million), with 4-25 olfactory cilia per cell.
Sustentacular Cells: Produce mucus and maintain ionic and molecular environment.
Basal Cells: Replace worn-out olfactory cells with an average lifespan of 1-2 months.
Bowman’s Gland: Secretes mucus.
Stimulation of Olfactory Cells:
Odorant dissolves in mucus and attaches to receptors on olfactory cilia.
Involves a cascade effect through G-proteins and second messengers, leading to depolarization and action potential generation in the olfactory nerve.
Quality of a Good Odorant:
Small (3-20 Carbon atoms), volatile, water-soluble, and lipid-soluble.
Facilitated by odorant-binding proteins in mucus.
Membrane Potential and Action Potential:
Resting membrane potential: -55mV.
Action potential frequency in the olfactory nerve increases with odorant strength.
Adaptation Towards the Sense of Smell:
Rapid adaptation within the first second, with further slow adaptation.
Psychological adaptation greater than receptor adaptation, involving feedback inhibition from the central nervous system.
Primary Sensations of Smell:
Camphoraceous, Musky, Floral, Pepperminty, Ethereal, Pungent, Putrid.
Odor Detection Threshold:
Examples: Hydrogen sulfide (0.0005 ppm), Methyl-mercaptan (0.002 ppm).
Some toxic substances are odorless at lethal concentrations.
Characteristics of Smell:
Odor blindness for single substances due to lack of appropriate receptor protein.
Behavioral and emotional influences of smell.
Transmission of Olfactory Signals:
From olfactory cells to glomeruli in the olfactory bulb, involving lateral inhibition.
Primitive, less old, and new olfactory systems with different path
Title: Sense of Taste
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the structure and function of taste buds.
Describe the relationship between the taste threshold and taste index of common substances.
Explain the chemical basis and signal transduction of taste perception for each type of primary taste sensation.
Recognize different abnormalities of taste perception and their causes.
Key Topics:
Significance of Taste Sensation:
Differentiation between pleasant and harmful food
Influence on behavior
Selection of food based on metabolic needs
Receptors of Taste:
Taste buds on the tongue
Influence of sense of smell, texture of food, and pain stimulation (e.g., by pepper)
Primary and Secondary Taste Sensations:
Primary taste sensations: Sweet, Sour, Salty, Bitter, Umami
Chemical basis and signal transduction mechanisms for each taste
Taste Threshold and Index:
Taste threshold values for Sweet (sucrose), Salty (NaCl), Sour (HCl), and Bitter (Quinine)
Taste index relationship: Inversely proportional to taste threshold
Taste Blindness:
Inability to taste certain substances, particularly thiourea compounds
Example: Phenylthiocarbamide
Structure and Function of Taste Buds:
Composition: Epithelial cells, Sustentacular/Supporting cells, Taste cells, Basal cells
Features: Taste pores, Taste hairs/microvilli, and Taste nerve fibers
Location of Taste Buds:
Found in papillae of the tongue (Fungiform, Circumvallate, Foliate)
Also present on the palate, tonsillar pillars, epiglottis, and proximal esophagus
Mechanism of Taste Stimulation:
Interaction of taste substances with receptors on microvilli
Signal transduction pathways for Umami, Sweet, Bitter, Sour, and Salty tastes
Taste Sensitivity and Adaptation:
Decrease in sensitivity with age
Rapid adaptation of taste sensation
Role of Saliva in Taste:
Dissolution of tastants to reach receptors
Washing away the stimulus
Taste Preferences and Aversions:
Mechanisms behind taste preference and aversion
Influence of receptors and neural pathways
Impact of Sensory Nerve Damage:
Degeneration of taste buds if the sensory nerve fiber is cut
Abnormalities of Taste Detection:
Conditions: Ageusia, Hypogeusia, Dysgeusia (parageusia)
Causes: Nerve damage, neurological disorders, infections, poor oral hygiene, adverse drug effects, deficiencies, aging, tobacco use, altered neurotransmitter levels
Neurotransmitters and Taste Threshold:
Effects of serotonin (5-HT) and norepinephrine (NE) on taste sensitivity
Supertasters:
25% of the population with heightened sensitivity to taste, especially bitterness
Increased number of fungiform papillae
New Drug Discovery and Development .....NEHA GUPTA
The "New Drug Discovery and Development" process involves the identification, design, testing, and manufacturing of novel pharmaceutical compounds with the aim of introducing new and improved treatments for various medical conditions. This comprehensive endeavor encompasses various stages, including target identification, preclinical studies, clinical trials, regulatory approval, and post-market surveillance. It involves multidisciplinary collaboration among scientists, researchers, clinicians, regulatory experts, and pharmaceutical companies to bring innovative therapies to market and address unmet medical needs.
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists Saeid Safari
Preoperative Management of Patients on GLP-1 Receptor Agonists like Ozempic and Semiglutide
ASA GUIDELINE
NYSORA Guideline
2 Case Reports of Gastric Ultrasound
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journeygreendigital
Tom Selleck, an enduring figure in Hollywood. has captivated audiences for decades with his rugged charm, iconic moustache. and memorable roles in television and film. From his breakout role as Thomas Magnum in Magnum P.I. to his current portrayal of Frank Reagan in Blue Bloods. Selleck's career has spanned over 50 years. But beyond his professional achievements. fans have often been curious about Tom Selleck Health. especially as he has aged in the public eye.
Follow us on: Pinterest
Introduction
Many have been interested in Tom Selleck health. not only because of his enduring presence on screen but also because of the challenges. and lifestyle choices he has faced and made over the years. This article delves into the various aspects of Tom Selleck health. exploring his fitness regimen, diet, mental health. and the challenges he has encountered as he ages. We'll look at how he maintains his well-being. the health issues he has faced, and his approach to ageing .
Early Life and Career
Childhood and Athletic Beginnings
Tom Selleck was born on January 29, 1945, in Detroit, Michigan, and grew up in Sherman Oaks, California. From an early age, he was involved in sports, particularly basketball. which played a significant role in his physical development. His athletic pursuits continued into college. where he attended the University of Southern California (USC) on a basketball scholarship. This early involvement in sports laid a strong foundation for his physical health and disciplined lifestyle.
Transition to Acting
Selleck's transition from an athlete to an actor came with its physical demands. His first significant role in "Magnum P.I." required him to perform various stunts and maintain a fit appearance. This role, which he played from 1980 to 1988. necessitated a rigorous fitness routine to meet the show's demands. setting the stage for his long-term commitment to health and wellness.
Fitness Regimen
Workout Routine
Tom Selleck health and fitness regimen has evolved. adapting to his changing roles and age. During his "Magnum, P.I." days. Selleck's workouts were intense and focused on building and maintaining muscle mass. His routine included weightlifting, cardiovascular exercises. and specific training for the stunts he performed on the show.
Selleck adjusted his fitness routine as he aged to suit his body's needs. Today, his workouts focus on maintaining flexibility, strength, and cardiovascular health. He incorporates low-impact exercises such as swimming, walking, and light weightlifting. This balanced approach helps him stay fit without putting undue strain on his joints and muscles.
Importance of Flexibility and Mobility
In recent years, Selleck has emphasized the importance of flexibility and mobility in his fitness regimen. Understanding the natural decline in muscle mass and joint flexibility with age. he includes stretching and yoga in his routine. These practices help prevent injuries, improve posture, and maintain mobilit
Ethanol (CH3CH2OH), or beverage alcohol, is a two-carbon alcohol
that is rapidly distributed in the body and brain. Ethanol alters many
neurochemical systems and has rewarding and addictive properties. It
is the oldest recreational drug and likely contributes to more morbidity,
mortality, and public health costs than all illicit drugs combined. The
5th edition of the Diagnostic and Statistical Manual of Mental Disorders
(DSM-5) integrates alcohol abuse and alcohol dependence into a single
disorder called alcohol use disorder (AUD), with mild, moderate,
and severe subclassifications (American Psychiatric Association, 2013).
In the DSM-5, all types of substance abuse and dependence have been
combined into a single substance use disorder (SUD) on a continuum
from mild to severe. A diagnosis of AUD requires that at least two of
the 11 DSM-5 behaviors be present within a 12-month period (mild
AUD: 2–3 criteria; moderate AUD: 4–5 criteria; severe AUD: 6–11 criteria).
The four main behavioral effects of AUD are impaired control over
drinking, negative social consequences, risky use, and altered physiological
effects (tolerance, withdrawal). This chapter presents an overview
of the prevalence and harmful consequences of AUD in the U.S.,
the systemic nature of the disease, neurocircuitry and stages of AUD,
comorbidities, fetal alcohol spectrum disorders, genetic risk factors, and
pharmacotherapies for AUD.
7. Dengue in World 100 million infections year 250 thousand hemorrhagic fever 25 thousand deaths. 2.7 billion people at risk Incidence has quadrupled since 1985 - WHO, 2006 Murray et al. (2002) Medical Microbiology. 4th edition. St. Louis: Mosby. Pages 561-564 ■ DENGUE ■ VECTORS ONLY
12. August 12th, 2007 posted by Kelly Burkholder-Allen August 12, 2007 @ 9:55 am According to the CDC, the Rio Grande Valley is at risk for dengue fever CDC warns of increased risk of dengue fever in RGV By MELISSA McEVER - The Brownsville Herald Catching dengue fever is a real risk… local health officials should be on the lookout for its symptoms, according to a new report from the CDC. The region is seeing more cases of dengue and hemorrhagic fever, a life-threatening complication of the mosquito-borne virus, than in past. In 2005, Officials reported a large-scale dengue outbreak that included 223 cases of hemorrhagic fever, and that same year 24 dengue cases were reported in Cameron County – including a Brownsville woman who became seriously ill. In an outbreak investigation, the CDC and officials from the Texas Health Services found that the woman and two other Cameron County residents, had contracted dengue fever locally rather than in Mexico. That finding was surprising, because most dengue cases are imported from other countries, officials said . “These were the first cases that were locally acquired,” said Dr. Brian Smith, regional director for the Texas Health Services’ Region 11, which includes the Valley. The findings suggest that dengue’s reach is growing beyond its usual borders…
13.
14.
15.
16.
17. First Documented Case Transfusion Transmitted Dengue Virus Infection. Rapid Detection and Typing of Dengue Virus from Clinical Samples by RNA-PCR. Lanciotti RS, Calisher CH, Gubler DJ, Chang GJ and Vorndam AD. JCM 1992; 30: 545-51 C. K. Lin – Hong Kong St. Mary Hospital Red Cross Blood Transfusion Service, 1992
18. Estimated risk of transmission of dengue virus through blood transfusion in Puerto Rico. Beatty ME, Biggerstaff B, Rigau J, Petersen L. (#126). At 5th International Conference on Emerging Infectious Diseases. Atlanta, GA. March 19-22, 2006.
19.
20. Dengue Infection by Blood Transfusion Real Risk: 1:1000 Risk will vary worldwide depending on endemicity (Brazil, 2.4 million blood collections/year)
21. Approach: All Donated Blood at Dengue Endemic Regions Must be Tested for Dengue NS1 Antigen.
22.
23.
24.
25.
26.
27.
28. Estacio Ferreira Ramos, M.D. Blood Banker, Hematologist Pathologist Carlos Carl Ehrich Medical Research Salvador, Bahia - Brazil [email_address] Skype: esfera2k Mobile: +55(71) 9956-0635 Hospital Portugues Blood Bank +55(71)3203-5555 Scientific Director UMA – Universidade da Mata Atlântica Representative in Brazil, Worldwatch Institute www.wwiuma.org.br
29. References Gubler DJ. The global emergence/resurgence of arboviral diseases as public health problems. Arch Med Res. 2002;33:330-42. Pan American Health Organization. 2005: Number of reported cases of dengue & dengue hemorrhagic fever (DHF), Region of the Americas (by country And subregion). http://www.paho.org/English/AD/DPC/CD/dengue- cases-2005.htm Kouri GP, Guzman MG, Bravo JR, Triana C. Dengue haemorrhagic fever/dengue shock syndrome: lessons from the Cuban epidemic, 1981. Bull World Health Organ. 1989;67:375-80. Pan American Health Organization. Dengue hemorrhagic fever in Venezuela Epidemiol Bull. 1990;11:7-9. CDC. Dengue–Texas. MMWR Morbid Mortal Wkly Rep. 1980;29:451. Lacayo M, Taylor R, Duran H, Abell A, et al. Outbreak investigation of dengue. Texas, 2005 (Late-breaker). 54th Annual Meeting: American Society of Tropical Medicine and Hygiene. Washington, DC, December, 2005.